We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Announces Public Hearing on Blood Substitute
FDA Announces Public Hearing on Blood Substitute
November 29, 2006
The FDA’s Blood Products Advisory Committee will hold a public hearing next month to consider a request by the Naval Medical Research Center to conduct a clinical trial of Biopure’s blood substitute, Hemopure.